Johns, Christopher http://orcid.org/0000-0001-7589-7279
Montalvo, Steven K. http://orcid.org/0000-0003-1519-2829
Cauble, M’Kay http://orcid.org/0000-0002-6560-8434
Liu, Yu-Lun http://orcid.org/0000-0003-3541-1814
All, Sean http://orcid.org/0000-0002-2277-2226
Rahimi, Asal S. http://orcid.org/0000-0002-2762-5049
Alluri, Prasanna G. http://orcid.org/0000-0001-7517-9525
Leitch, Marilyn http://orcid.org/0000-0001-6959-0078
Unni, Nisha http://orcid.org/0000-0003-1549-4720
Wooldridge, Rachel http://orcid.org/0000-0003-4840-2829
Farr, Deborah http://orcid.org/0000-0003-0571-3811
Nwachukwu, Chika http://orcid.org/0000-0001-9732-9352
Kim, D. W. Nathan http://orcid.org/0000-0002-4450-3318
Article History
Received: 12 December 2022
Accepted: 17 March 2023
First Online: 30 March 2023
Declarations
:
: The authors have no relevant financial interests to disclose. Non-financial interests: Dr. Unni has served on advisory boards for Pfizer, Eli Lilly, Novartis, Macrogenics, Biotheranostics, and Eisai.